AbbVie Inc. (ABBV) Covered Calls

AbbVie Inc is a research-based biopharmaceutical company. Its products are used to treat diseases including rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications.

You can sell covered calls on AbbVie Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ABBV (prices last updated Fri 4:16 PM ET):

AbbVie Inc. (ABBV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
164.99 -4.64 165.00 165.10 11.2M 59 300
Covered Calls For AbbVie Inc. (ABBV)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 165 4.55 160.55 2.8% 28.4%
Jan 17 165 6.20 158.90 4.9% 27.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease, ulcerative colitis, and complications associated with chronic kidney disease, among other indications. It also has a pipeline of new medicines, including various compounds or indications in Phase II or Phase III development across such medical specialties as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. The company was founded on April 10, 2012 and is headquartered in North Chicago, IL.